These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 7490245)

  • 21. [Determination of the degree of morphological regression following chemotherapy in malignant bone tumors].
    Salzer-Kuntschik M; Brand G; Delling G
    Pathologe; 1983 May; 4(3):135-41. PubMed ID: 6576329
    [No Abstract]   [Full Text] [Related]  

  • 22. Prognostic factors among 130 patients with osteosarcoma.
    Pochanugool L; Subhadharaphandou T; Dhanachai M; Hathirat P; Sangthawan D; Pirabul R; Onsanit S; Pornpipatpong N
    Clin Orthop Relat Res; 1997 Dec; (345):206-14. PubMed ID: 9418642
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Biodegradable cisplatin polymer in limb-sparing surgery for canine osteosarcoma.
    Withrow SJ; Liptak JM; Straw RC; Dernell WS; Jameson VJ; Powers BE; Johnson JL; Brekke JH; Douple EB
    Ann Surg Oncol; 2004 Jul; 11(7):705-13. PubMed ID: 15231525
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Use of intra-arterial chemotherapy and embolization before limb salvage surgery for osteosarcoma of the lower extremity.
    Zhang HJ; Yang JJ; Lu JP; Lai CJ; Sheng J; Li YX; Hao Q; Zhang SM; Gupta S
    Cardiovasc Intervent Radiol; 2009 Jul; 32(4):672-8. PubMed ID: 19296158
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interferon-alpha as the only adjuvant treatment in high-grade osteosarcoma: long term results of the Karolinska Hospital series.
    Müller CR; Smeland S; Bauer HC; Saeter G; Strander H
    Acta Oncol; 2005; 44(5):475-80. PubMed ID: 16118081
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tissue necrosis after chemotherapy in osteosarcoma as the important prognostic factor.
    Sami SH; Rafati AH; Hodjat P
    Saudi Med J; 2008 Aug; 29(8):1124-9. PubMed ID: 18690304
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of primary osteosarcoma of flat bones with secondary osteosarcoma of any site.
    Pratt CB; Meyer WH; Rao BN; Pappo AS; Fleming ID; Luo X; Cain A; Kaste SC; Shearer PD; Jenkins JJ
    Cancer; 1997 Sep; 80(6):1171-7. PubMed ID: 9305720
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adjuvant therapy of osteosarcoma--A Phase II trial: Southwest Oncology Group study 9139.
    Zalupski MM; Rankin C; Ryan JR; Lucas DR; Muler J; Lanier KS; Budd GT; Biermann JS; Meyers FJ; Antman K
    Cancer; 2004 Feb; 100(4):818-25. PubMed ID: 14770440
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Biopsy technique in the treatment of osteosarcoma.
    Cara del Rosal JA; Cañadell J
    Int Orthop; 1994; 18(6):375-8. PubMed ID: 7698871
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Custom prosthetic reconstruction for proximal tibial osteosarcoma with proximal tibiofibular joint involved.
    Zhang Y; Yang Z; Li X; Chen Y; Zhang S; Du M; Li J
    Surg Oncol; 2008 Aug; 17(2):87-95. PubMed ID: 18160278
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The role of polychemotherapy in the management of malignant bone tumors].
    Reichardt P; Dörken B
    Chirurg; 2002 Dec; 73(12):1170-3. PubMed ID: 12491045
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Practical approach to processing osteosarcomas in the surgical pathology laboratory.
    Wold LE
    Pediatr Dev Pathol; 1998; 1(5):449-54. PubMed ID: 9688771
    [No Abstract]   [Full Text] [Related]  

  • 33. Primary osteoliposarcoma of the bone.
    De Padua M; Bhandari TP; Pingle J
    Indian J Pathol Microbiol; 2009; 52(1):80-2. PubMed ID: 19136790
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Salvage surgery treatment in osteosarcoma of the fibula with seventeen years survival].
    Lumbreras R; Castro A; Val S; Modrego FJ; Bello ML
    Rev Fac Cien Med Univ Nac Cordoba; 2007; 64(1):38-41. PubMed ID: 18426095
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [A rapid colorimetric assay for viability of osteosarcoma cells after chemotherapy].
    Chen Q; Zhang JH; Chen JT; Shi ZJ; Deng YJ
    Nan Fang Yi Ke Da Xue Xue Bao; 2009 Dec; 29(12):2490-1. PubMed ID: 20034909
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Margins, necrosis and local recurrence after conservative surgery in osteosarcoma.
    Picci P; Capanna R; Bacci G; Mercuri M; Biagini R; Ruggieri P; Ferraro A; De Cristofaro R; Ferruzzi A; Campanacci M
    Chir Organi Mov; 1990; 75(1 Suppl):82-5. PubMed ID: 2249566
    [No Abstract]   [Full Text] [Related]  

  • 37. [Possibilities and perspectives of adjuvant chemotherapy in malignant tumors].
    Tanneberger S
    Vopr Onkol; 1989; 35(8):899-904. PubMed ID: 2800442
    [No Abstract]   [Full Text] [Related]  

  • 38. [Results of treatment for osteosarcoma in children and youth].
    Nurzyńska-Flak J; Katski K; Zawitkowska-Klaczyńska J; Mazurkiewicz T; Kowalczyk JR
    Med Wieku Rozwoj; 2004; 8(4 Pt 2):1037-40. PubMed ID: 15951598
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Osteosarcoma. Clinical and pathological considerations.
    Klein MJ; Kenan S; Lewis MM
    Orthop Clin North Am; 1989 Jul; 20(3):327-45. PubMed ID: 2662111
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Angiographic evaluation of the response of osteosarcoma to neoadjuvant chemotherapy].
    Albisinni U; Galletti S; Manfrini M; Pignatti G; Biagini R; Picci P; Bacci G; Capanna R
    Radiol Med; 1988 Apr; 75(4):381-5. PubMed ID: 3163813
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.